Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8′ ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers

被引:84
作者
Gregson, SJ
Howard, PW
Gullick, DR
Hamaguchi, A
Corcoran, KE
Brooks, NA
Hartley, JA
Jenkins, TC
Patel, S
Guille, MJ
Thurston, DE
机构
[1] Univ London, Sch Pharm, Canc Res UK, Gene Targeted Drug Design Res Grp, London WC1N 1AX, England
[2] UCL, Dept Oncol, Canc Res UK, Drug DNA Interact Res Grp, London W1W 7BS, England
[3] Univ Bradford, Tom Connors Canc Res Ctr, Yorkshire Canc Res Lab Drug Design, Bradford BD7 1DP, W Yorkshire, England
[4] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth PO1 2DT, Hants, England
关键词
D O I
10.1021/jm030897l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A C2/C2'-exo-unsaturated pyrrolo [2, 1-c] [1,4]benzodiazepine (PBD) dimer 4b (DRG-16) with a C8-O(CH2)(n)O-C8' diether linkage (n = 5) has been synthesized that shows markedly superior in vitro cytotoxic potency (e.g., > 3400-fold in IGROV1 ovarian cells) and interstrand DNA cross-linking reactivity (> 10-fold) compared to the shorter homologue 4a (SJG-136; n = 3). In contrast, for the C-ring unsubstituted series, the corresponding n = 5 dimer (3c) is generally less cytotoxic and has a lower interstrand cross-linking reactivity compared to its shorter n = 3 homologue (3a). Dimer 4b cross-links DNA with > 10-fold efficiency compared to 4a, and also inhibits the activity of the restriction endonuclease BamH1 more efficiently than either 3a or 4a. The C2-exo-unsaturated PBD dimers 4a,b are not only more effective than their C-ring saturated counterparts in terms of induced DeltaT(m) shift, but they also exert this effect more rapidly. Thus, while 3a and 3c exert 68 and 35% of their maximum effect immediately upon interaction with DNA, this level increases to 76 and 97% for 4a and 4b, respectively. Molecular modeling shows a rank order of 4b (n = 5) > 4a (n = 3) > 3a (n = 3) > 3c (n = 5) in terms of binding energy toward duplexes containing embedded target 5'-GAT(1-2)C cross-link sequences, reflecting the superior fit of the C2-exo-unsaturated rather than saturated C-rings of the PBD dimers. A novel synthesis of core synthetic building blocks for PBD dimers via stepwise Mitsunobu reaction and nitration with Cu(NO3)(2) is also reported.
引用
收藏
页码:1161 / 1174
页数:14
相关论文
共 29 条
  • [21] HETEROGENEITY IN RADIATION-INDUCED DNA DAMAGE AND REPAIR IN TUMOR AND NORMAL-CELLS MEASURED USING THE COMET ASSAY
    OLIVE, PL
    BANATH, JP
    DURAND, RE
    [J]. RADIATION RESEARCH, 1990, 122 (01) : 86 - 94
  • [22] A QUANTITATIVE ASSAY TO MEASURE THE RELATIVE DNA-BINDING AFFINITY OF PYRROLO[2,1-C][1,4]BENZODIAZEPINE (PBD) ANTITUMOR ANTIBIOTICS BASED ON THE INHIBITION OF RESTRICTION-ENDONUCLEASE BAMHI
    PUVVADA, MS
    HARTLEY, JA
    JENKINS, TC
    THURSTON, DE
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (16) : 3671 - 3675
  • [23] The Xplor-NIH NMR molecular structure determination package
    Schwieters, CD
    Kuszewski, JJ
    Tjandra, N
    Clore, GM
    [J]. JOURNAL OF MAGNETIC RESONANCE, 2003, 160 (01) : 65 - 73
  • [24] Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: Kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers
    Smellie, M
    Bose, DS
    Thompson, AS
    Jenkins, TC
    Hartley, JA
    Thurston, DE
    [J]. BIOCHEMISTRY, 2003, 42 (27) : 8232 - 8239
  • [25] CELLULAR PHARMACOLOGY OF NOVEL C8-LINKED ANTHRAMYCIN-BASED SEQUENCE-SELECTIVE DNA MINOR-GROOVE CROSS-LINKING AGENTS
    SMELLIE, M
    KELLAND, LR
    THURSTON, DE
    SOUHAMI, RL
    HARTLEY, JA
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (01) : 48 - 53
  • [26] ANTHRAMYCIN INHIBITION OF RESTRICTION ENDONUCLEASE CLEAVAGE AND ITS USE AS A REVERSIBLE BLOCKING-AGENT IN DNA CONSTRUCTIONS
    SUMNER, W
    BENNETT, GN
    [J]. NUCLEIC ACIDS RESEARCH, 1981, 9 (09) : 2105 - 2119
  • [27] Thurston D.E., 1993, MOL ASPECTS ANTICANC, P54
  • [28] Synthesis of sequence-selective C8-linked pyrrolo[2,1-c][1,4]benzodiazepine DNA interstrand cross-linking agents
    Thurston, DE
    Bose, DS
    Thompson, AS
    Howard, PW
    Leoni, A
    Croker, SJ
    Jenkins, TC
    Neidle, S
    Hartley, JA
    Hurley, LH
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (23) : 8141 - 8147
  • [29] Preclinical pharmacology and antitumour activity of the novel sequence selective DNA minor-groove cross linking agent DSB 120
    Walton, MI
    Goddard, P
    Kelland, LR
    Thurston, DE
    Harrap, KR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (05) : 431 - 438